BL&H Co Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:BL&H Co Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10846
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BL&H Co Ltd (BL&H), a subsidiary of STADA Pharmaceuticals (Asia) Ltd is a drug company that manufactures and markets diagnostic test kits and drugs. The company offers products including aridol bronchial challenge test kit, cetraxal plus ear drop, al-sense amniotic leak test kit, DC bead-drug eluting beads, Lung Flute, OTC products, and ETC products. It provides products such as metoject, microshield, microshield antimicrobial hand gel, mutaflor cap, mutaflor sus, orfadin cap., sweatrol pad solution, trisenox inj. and others. BL&H’s products are used for the treatment of acute external otitis and rheumatoid arthritis; prevention of arteriosclerosis; and diagnosis of hereditary tyrosinemia type 1. The company has its presence in the US and Korea. BL&H is headquartered in Seoul, South Korea.

BL&H Co Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BL&H Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BL&H Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BL&H Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BL&H Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BL&H Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
BL&H Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
BL&H Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Theratechnologies Enters into Commercialization Agreement with BL&H 11
Licensing Agreements 12
BL&H Enters into Licensing Agreement with Race Oncology 12
BL&H Enter into Licensing Agreement with MDNA Life Sciences 13
BL&H Enters into Licensing Agreement with Telesta Therapeutics 14
Clinigen Enters Into Licensing Agreement With BL&H For Foscavir 15
Equity Offering 16
Telesta Therapeutics Raises USD0.2 Million in Private Placement of Shares 16
BL&H Co Ltd – Key Competitors 17
BL&H Co Ltd – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
BL&H Co Ltd, Pharmaceuticals & Healthcare, Key Facts 2
BL&H Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BL&H Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BL&H Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BL&H Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
BL&H Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
BL&H Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Theratechnologies Enters into Commercialization Agreement with BL&H 11
BL&H Enters into Licensing Agreement with Race Oncology 12
BL&H Enter into Licensing Agreement with MDNA Life Sciences 13
BL&H Enters into Licensing Agreement with Telesta Therapeutics 14
Clinigen Enters Into Licensing Agreement With BL&H For Foscavir 15
Telesta Therapeutics Raises USD0.2 Million in Private Placement of Shares 16
BL&H Co Ltd, Key Competitors 17
BL&H Co Ltd, Other Locations 18

List of Figures
BL&H Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
BL&H Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
BL&H Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
BL&H Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
BL&H Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BL&H Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
BL&H Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BL&H Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BL&H Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[BL&H Co Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Telekom Austria AG:企業の戦略・SWOT・財務情報
    Telekom Austria AG - Strategy, SWOT and Corporate Finance Report Summary Telekom Austria AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Jointown Pharmaceutical Group Co., Ltd.の企業概要及び財務/SWOT分析
    Jointown Pharmaceutical Group Co., Ltd. Fundamental Company Report is an absolutely essential resource for anyone looking for detailed information on the above-mentioned company. Using a wide range of primary and secondary sources, we combined, analyzed and presented all available data about Jointow …
  • National Agricultural Holdings Limited (1236):企業の財務及び戦略的SWOT分析
    Summary National Agricultural Holdings Limited (National Agricultural) is a holding company that integrates financial services, agricultural product trading, industry and science research. The company operates through business segments such as Rural Finance, Agricultural Product Trading and High-tec …
  • JSC “Arhenergosbyt”:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' JSC "Arhenergosbyt" Mergers and …
  • American Science & Engineering, Inc.:企業の戦略・SWOT・財務情報
    American Science & Engineering, Inc. - Strategy, SWOT and Corporate Finance Report Summary American Science & Engineering, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Scinopharm Taiwan Limited (1789):企業概要、財務及び戦略的SWOT分析
    Summary ScinoPharm Taiwan, Ltd. (ScinoPharm) is a pharmaceutical company. The company develops and manufactures APIs and intermediates for pharmaceutical industry. Its products include atazanavir sulfate, benazepril hydrochloride, docetaxel anhydrous, flavoxate hydrochloride, galantamine hydrobromid …
  • BNK Petroleum Inc (BKX):石油・ガス:M&Aディール及び事業提携情報
    Summary BNK Petroleum Inc (BNK Petroleum) is an oil and gas company. The company explores, produces and acquires large hydrocarbon reserves. The company’s project includes Tishomingo Field, Gapowo B-1 well and other operations in Spain. Its Tishomingo Field is located in Ardmore Basin in Oklahoma, t …
  • Photon Group Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Photon Group Limited Mergers an …
  • Cellceutix Corporation (CTIX):企業の財務及び戦略的SWOT分析
    Summary Cellceutix Corporation (Cellceutix) is a clinical stage biopharmaceutical company which develops small molecule therapies in the areas of unmet medical needs in the areas of onocology, antimicrobial and dermatology applications. The company’s pipeline product portfolio includes kevetrin for …
  • Mecklenburg Electric Cooperative:発電所・企業SWOT分析
    Mecklenburg Electric Cooperative - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on …
  • Syngen Biotech Co Ltd (8279):製薬・医療:M&Aディール及び事業提携情報
    Summary Syngen Biotech Co Ltd (Syngen) is a biotechnology company. The company manufactures and supplies active pharmaceutical ingredients (APIs), biology fermentation products, nutritional ingredients, nutraceutical ingredients, biology agriculture and aquaculture products, and functional food prod …
  • Euromedic International N.V.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Euromedic International N.V. Me …
  • Sumitomo Heavy Industries Ltd (6302):電力:M&Aディール及び事業提携情報
    Summary Sumitomo Heavy Industries Ltd (Sumitomo) is a manufacturer of industrial machinery. The company offers a range of products, which include pumps, steam turbines, energy plants, iron and steel manufacturing machinery, cryogenics, environmental systems. It also provides water treatment plants, …
  • Suzhou Xinrong Best Medical Instrument Co Ltd-医療機器分野:企業M&A・提携分析
    Summary Suzhou Xinrong Best Medical Instrument Co Ltd (Suzhou Xinrong) is a medical device company that manufactures orthopedic medical instruments. The company prvides products such as medullary cavity plug, acetabular screws, metal ball head, stem and titanium plate anterior thoracolumbar fixed eq …
  • Mermaid Maritime Public Company Limited (DU4):企業概要、財務及び戦略的SWOT分析
    Summary Mermaid Maritime Public Company Limited (Mermaid Maritime) is a subsea and drilling services provider. The company provides subsea and drilling service for the offshore oil and gas industry. It offers services such as mermaid offshore services and drilling services. Mermaid Maritime's offsho …
  • Nippon Soda Co., Ltd. (4041):企業の財務・戦略的SWOT分析
    Nippon Soda Co., Ltd. (4041) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Memphasys Ltd (MEM)-製薬・医療分野:企業M&A・提携分析
    Summary Memphasys Ltd (Memphasys), formerly Nusep Holdings Ltd is a life science company that develops and sells pre-cast electrophoresis gels, separations equipment and consumables, analytical software, and other biological products. The company offers gels which include tris glycine, and tris hepe …
  • Cellerant Therapeutics, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Cellerant Therapeutics, Inc. Me …
  • Cox and Kings Limited:企業の戦略・SWOT・財務分析
    SummaryCox and Kings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key F …
  • Joerns Healthcare Inc.:(医療機器分野)企業M&A及び提携動向
    Summary Joerns Healthcare Inc. (Joerns) is a medical equipment manufacturer. The company manufactures and rents healing and prevention products and services to the post-acute healthcare markets. It offers bed frames, prevention surfaces and positioners, therapeutic support surfaces, fluid immersion …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆